glycyrrhizic acid has been researched along with diflunisal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, A; Cecchinato, V; D'Agostino, G; Danelon, G; Fassi, EMA; Garofalo, M; Grazioso, G; Pedotti, M; Sgrignani, J; Simonelli, L; Uguccioni, M; Varani, L | 1 |
| Bianchi, ME; Casalgrandi, M; De Leo, F; De Marchis, F; Gori, A; Mannella, V; Mezzapelle, R; Musco, G; Preti, A; Quilici, G; Tirone, M; Zucchelli, C | 1 |
2 other study(ies) available for glycyrrhizic acid and diflunisal
| Article | Year |
|---|---|
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction.
Topics: Amino Acid Sequence; Animals; Cell Line; Cell Movement; Chemokine CXCL12; HMGB1 Protein; Humans; Mice; Molecular Docking Simulation; Peptides; Protein Binding; Receptors, CXCR4 | 2021 |
Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.
Topics: 3T3 Cells; Animals; Chemokine CXCL12; Chemotaxis; Diflunisal; Disulfides; Glycyrrhizic Acid; HMGB1 Protein; Humans; Inflammation; Leukocytes; Macrophages; Magnetic Resonance Spectroscopy; Mice | 2019 |